These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
240 related articles for article (PubMed ID: 33343564)
1. Differential Skewing of Circulating MR1-Restricted and γδ T Cells in Human Psoriasis Vulgaris. Plužarić V; Štefanić M; Mihalj M; Tolušić Levak M; Muršić I; Glavaš-Obrovac L; Petrek M; Balogh P; Tokić S Front Immunol; 2020; 11():572924. PubMed ID: 33343564 [TBL] [Abstract][Full Text] [Related]
2. Recognition of the antigen-presenting molecule MR1 by a Vδ3 Rice MT; von Borstel A; Chevour P; Awad W; Howson LJ; Littler DR; Gherardin NA; Le Nours J; Giles EM; Berry R; Godfrey DI; Davey MS; Rossjohn J; Gully BS Proc Natl Acad Sci U S A; 2021 Dec; 118(49):. PubMed ID: 34845016 [TBL] [Abstract][Full Text] [Related]
3. Human liver CD8 Rha MS; Han JW; Kim JH; Koh JY; Park HJ; Kim SI; Kim MS; Lee JG; Lee HW; Lee DH; Kim W; Park JY; Joo DJ; Park SH; Shin EC J Hepatol; 2020 Sep; 73(3):640-650. PubMed ID: 32247824 [TBL] [Abstract][Full Text] [Related]
4. Characterization of the TCRβ repertoire of peripheral MR1-restricted MAIT cells in psoriasis vulgaris patients. Jirouš Drulak M; Grgić Z; Plužarić V; Šola M; Opačak-Bernardi T; Viljetić B; Glavaš K; Tolušić-Levak M; Periša V; Mihalj M; Štefanić M; Tokić S Sci Rep; 2023 Nov; 13(1):20990. PubMed ID: 38017021 [TBL] [Abstract][Full Text] [Related]
7. The miR-20a/miR-92b Profile Is Associated with Circulating γδ T-Cell Perturbations in Mild Psoriasis. Tokić S; Jirouš M; Plužarić V; Mihalj M; Šola M; Tolušić Levak M; Glavaš K; Balogh P; Štefanić M Int J Mol Sci; 2023 Feb; 24(5):. PubMed ID: 36901753 [TBL] [Abstract][Full Text] [Related]
8. Dual TCR-α Expression on Mucosal-Associated Invariant T Cells as a Potential Confounder of TCR Interpretation. Suliman S; Kjer-Nielsen L; Iwany SK; Lopez Tamara K; Loh L; Grzelak L; Kedzierska K; Ocampo TA; Corbett AJ; McCluskey J; Rossjohn J; León SR; Calderon R; Lecca-Garcia L; Murray MB; Moody DB; Van Rhijn I J Immunol; 2022 Mar; 208(6):1389-1395. PubMed ID: 35246495 [TBL] [Abstract][Full Text] [Related]
9. MR1-restricted mucosal-associated invariant T (MAIT) cells respond to mycobacterial vaccination and infection in nonhuman primates. Greene JM; Dash P; Roy S; McMurtrey C; Awad W; Reed JS; Hammond KB; Abdulhaqq S; Wu HL; Burwitz BJ; Roth BF; Morrow DW; Ford JC; Xu G; Bae JY; Crank H; Legasse AW; Dang TH; Greenaway HY; Kurniawan M; Gold MC; Harriff MJ; Lewinsohn DA; Park BS; Axthelm MK; Stanton JJ; Hansen SG; Picker LJ; Venturi V; Hildebrand W; Thomas PG; Lewinsohn DM; Adams EJ; Sacha JB Mucosal Immunol; 2017 May; 10(3):802-813. PubMed ID: 27759023 [TBL] [Abstract][Full Text] [Related]
10. Mouse mucosal-associated invariant T cell receptor recognition of MR1 presenting the vitamin B metabolite, 5-(2-oxopropylideneamino)-6-d-ribitylaminouracil. Ciacchi L; Mak JYW; Le JP; Fairlie DP; McCluskey J; Corbett AJ; Rossjohn J; Awad W J Biol Chem; 2024 May; 300(5):107229. PubMed ID: 38537698 [TBL] [Abstract][Full Text] [Related]
11. MR1-Restricted T Cells Are Unprecedented Cancer Fighters. Vacchini A; Chancellor A; Spagnuolo J; Mori L; De Libero G Front Immunol; 2020; 11():751. PubMed ID: 32411144 [TBL] [Abstract][Full Text] [Related]
12. Unique and Common Features of Innate-Like Human Vδ2 Provine NM; Binder B; FitzPatrick MEB; Schuch A; Garner LC; Williamson KD; van Wilgenburg B; Thimme R; Klenerman P; Hofmann M Front Immunol; 2018; 9():756. PubMed ID: 29740432 [TBL] [Abstract][Full Text] [Related]
13. MAIT Cells Promote Tumor Initiation, Growth, and Metastases via Tumor MR1. Yan J; Allen S; McDonald E; Das I; Mak JYW; Liu L; Fairlie DP; Meehan BS; Chen Z; Corbett AJ; Varelias A; Smyth MJ; Teng MWL Cancer Discov; 2020 Jan; 10(1):124-141. PubMed ID: 31826876 [TBL] [Abstract][Full Text] [Related]
14. The effects of 5-OP-RU stereochemistry on its stability and MAIT-MR1 axis. Matsuoka T; Motozono C; Hattori A; Kakeya H; Yamasaki S; Oishi S; Ohno H; Inuki S Chembiochem; 2021 Feb; 22(4):672-678. PubMed ID: 33034934 [TBL] [Abstract][Full Text] [Related]
15. Synthesis, stabilization, and characterization of the MR1 ligand precursor 5-amino-6-D-ribitylaminouracil (5-A-RU). Li K; Vorkas CK; Chaudhry A; Bell DL; Willis RA; Rudensky A; Altman JD; Glickman MS; Aubé J PLoS One; 2018; 13(2):e0191837. PubMed ID: 29401462 [TBL] [Abstract][Full Text] [Related]
16. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells. Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347 [TBL] [Abstract][Full Text] [Related]
20. MR1-restricted T cells: the new dawn of cancer immunotherapy. Wang Z; Wang M; Chen J; Zhang L; Zhang L; Yu L Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33185693 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]